Proton Therapy Systems Market - By Set-up Type (Single Room, Multiple Room), By Indication (Breast Cancer, Lung Cancer, Prostate Cancer, Gastro-intestinal Cancer, Brain Cancer), By End-use (Hospitals, Proton Therapy Centers) – Global Forecast to 2032
Published Date: July - 2024 | Publisher: MIR | No of Pages: 240 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationProton Therapy Systems Market Size
Proton Therapy Systems Market was valued at USD 1.2 billion in 2022 and is estimated to account for USD 3.2 billion by 2032.
Cancer is a major health concern worldwide, and its prevalence is increasing at an alarming rate. The World Cancer Research Fund International estimated that approximately 19 million new cancer cases were registered in 2021, and this number is anticipated to increase to 24 million by 2035, globally. Moreover, according to the American Cancer Society, around 1.9 million new cases of cancer were diagnosed in the U.S. alone in 2021. Thus, rise in the number of cancer cases is one of the major drivers of growth in the market.
Cancer patients are increasingly seeking non-invasive treatments, making proton therapy systems highly sought-after. Proton therapy uses targeted radiation to attack cancer cells, sparing nearby healthy tissues. This makes it an excellent choice for those looking to avoid the harsh side effects of surgery and chemotherapy. Proton therapy also has other benefitsit's highly precise, minimizing damage to normal tissues. This makes it particularly suitable for children, who are more vulnerable to the effects of radiation than adults. These factors are fueling the surge in demand for proton therapy systems.
| Report Attribute | Details |
|---|---|
| Base Year | 2022 |
| Proton Therapy Systems Market Size in 2022 | USD 1.2 Billion |
| Forecast Period | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR | 10.8% |
| 2032 Value Projection | USD 3.2 Billion |
| Historical Data for | 2018 to 2022 |
| No. of Pages | 150 |
| Tables, Charts & Figures | 261 |
| Segments covered | Set-up Type, Indication, End-use, and Region |
| Growth Drivers |
|
| Pitfalls & Challenges |
|
COVID-19 Impact
The COVID-19 pandemic had a considerable impact on the proton therapy systems market, particularly in terms of hospital-based implementation and operational response. The proton therapy market relies on complex and specialized equipment, including cyclotrons and synchrotrons, which are essential for generating proton beams. The pandemic disrupted global supply chains, causing delays in the delivery and installation of these critical components, impacting the expansion of proton therapy centers and maintenance of existing ones.
Moreover, the economic repercussions of the pandemic affected healthcare budgets, including funding for proton therapy facilities. Numerous hospitals and institutions faced financial strain, leading to budget cuts and reconsideration of capital-intensive projects such as the construction of new proton therapy centers. However, there are opportunities for growth as the healthcare landscape continues to evolve. Increased awareness of health, the integration of telehealth, and ongoing research and innovation may contribute to the resilience and expansion of the proton therapy market in a post-pandemic world.
Proton Therapy Systems Market Trends
Cancer remains a formidable threat to our health worldwide. Sadly, in 2020 alone, a staggering 19 million new cancer cases emerged. And the outlook for the future is grimestimates predict that by 2040, the number of annual new cancer cases could soar to 30 million. With countless lives affected by cancer year after year, it's imperative that we push the boundaries of cancer treatment. That's where proton therapy comes in – an innovative and incredibly precise form of radiation therapy that has captured the attention of medical experts and patients alike. As knowledge of proton therapy's advantages spreads, more and more individuals are turning to it for hope and a better chance at beating cancer.
Media coverage and success stories have played a role in boosting awareness and demand. In some regions, patient demand for proton therapy has led to longer waiting times for treatment due to the limited number of available centers. Thus, the rising cases of cancer are driving an increased demand for proton therapy as an effective and targeted treatment option will contribute to industry landscape.
Proton Therapy Systems Set-up Market Analysis
Imagine a hospital with a cutting-edge treatment option for certain types of cancerproton therapy. And guess what? You can choose between two different setups for this therapysingle-room or multiple-room. Now, the single-room setup is like a superhero in the proton therapy world. It's expected to grow by an amazing 10.5% each year! Why? Because it's a master at treating a variety of cancers, including those tricky ones like brain and spine tumors. It offers precision treatments, which is crucial for these sensitive areas. Plus, it's a speed demon! Single-room setups let doctors zap those tumors faster than traditional setups that involve hopping from room to room. This saves time for both patients and doctors. And hey, who doesn't love shorter waiting times and smoother scheduling?
The proton therapy systems market by application is categorized into breast cancer, lung cancer, prostate cancer, gastro-intestinal cancer, brain cancer, and others. The gastro-intestinal cancer segment accounted for USD 322 million revenue size in the year 2022. Globally, there were approximately 1.93 million cases reported in 2020 worldwide as it is the third most diagnosed cancer globally. Gastrointestinal cancers present a significant challenge in the realm of oncology, accounting for millions of new diagnoses and deaths annually. Traditional treatment approaches, including surgery, chemotherapy, and conventional radiation therapy, have been mainstays in combating these cancers.
However, the emergence of proton therapy has opened new avenues for more effective and less toxic treatments for gastrointestinal malignancies. In the context of GI cancers, where tumors are often located near critical structures such as the spinal cord, liver, or intestines, the ability to precisely target the tumor while minimizing damage to surrounding healthy tissues is of paramount importance. Proton therapy achieves this with unparalleled accuracy, reducing the risk of side effects and improving overall treatment outcomes.
Based on end-use, the proton therapy systems market is segmented into hospitals, proton therapy centers, and others. The hospitals segment accounted for 62% business share in the year 2022 and is anticipated to witness the highest growth during the forecast period. Hospitals, as the primary providers of cancer care, are key players in the growth and accessibility of proton therapy. Their recognition of the clinical benefits, commitment to patient-centered care, and role in research and innovation make them central to the expanding landscape of proton therapy.
Hospitals play a vital role in contributing to the scientific understanding of proton therapy's effectiveness through clinical research and data collection. As hospital demand continues to rise, the proton therapy market is poised to witness continued growth, offering hope and advanced treatment options to cancer patients worldwide. Therefore, patient convenience, higher R&D, advance technology are few factors that are estimated to remain at the forefront propelling the market for proton therapy systems.
In 2022, the proton therapy market in the U.S. generated around $530 million. And it's only expected to keep growing over the next few years. Why the surge in proton therapy? Well, it's a type of cancer treatment that has several benefitsit's more precise than traditional radiation, it's better at stopping tumors without harming healthy tissue, and it can be used to treat a wider range of cancers. So, hospitals and medical centers in the U.S. are building and updating their proton therapy facilities to meet the growing demand. They're also investing in research to learn more about how to use this treatment even more effectively. And as the healthcare system continues to advance and new ways to treat cancer are discovered, proton therapy is likely to play an increasingly important role. It's giving cancer patients more options and helping them fight the disease with a powerful, precise tool.
Proton Therapy Systems Market Share
Some of the eminent market participants operating in the proton therapy systems market include
- IBA worldwide
- Hitachi
- Mevion Medical Systems
- Optivus Proton Therapy
- Advanced Oncotherapy plc
- Mitsubishi Electric Corporation
- Varian
- Ion Beam Applications SA
- ProTom International
- Provision Healthcar
- Sumitomo Heavy Industries, Ltd.
These market players are undertaking several growth strategies including partnerships, collaborations, acquisitions & mergers, new product development & launches to strengthen their product portfolio as well as gain a competitive edge over others.
Proton Therapy Systems Industry News
- In December 2022, IBA won a contract for the installation of 10 proton therapy systems in Spain, which is being funded by the Amancio Ortega Foundation. The project is valued at over USD 229 million. The contract was signed with the Spanish Ministry of Health under a public-private partnership agreement. Such contract agreements strengthen the company’s position in the regional market.
- In October 2021, IBA launched a new interactive platform called Campus, which is dedicated to proton therapy. Campus is the world's first online proton therapy platform, and it is designed to provide a comprehensive and interactive learning experience for healthcare professionals, researchers, and patients. The launch of campus enhanced the accessibility and quality of proton therapy treatment and education, and it is considered as one of the significant developments in the field of proton therapy.
Proton therapy systems market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments
Click here to Buy Section of this Report
By Set-up Type (USD Million)
- Single room
- Multiple room
By Indication (USD Million)
- Breast cancer
- Lung cancer
- Prostate cancer
- Gastro-intestinal cancer
- Brain cancer
- Others
By End-use (USD Million)
- Hospitals
- Proton therapy centers
- Others
The above information is provided for the following regions and countries
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Switzerland
- The Netherlands
- Denmark
- Poland
- Sweden
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- New Zealand
- Thailand
- Vietnam
- Indonesia
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Middle East & Africa
- Saudi Arabia
- South Africa
- UAE
- Turkey
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy